INTERLEUKIN-6 LEVELS IN THE PLASMA OF PATIENTS WITH LYMPHOMA

被引：16

作者：

YEE, C ^{[1
]}

SUTCLIFFE, S ^{[1
]}

MESSNER, HA ^{[1
]}

MINDEN, MD ^{[1
]}

机构：

[1] ONTARIO CANC INST, DEPT MED & BIORES, 500 SHERBOURNE ST, TORONTO M4X 1K9, ONTARIO, CANADA

来源：

LEUKEMIA & LYMPHOMA | 1992年 / 7卷 / 1-2期

关键词：

IL-6; PLASMA; LYMPHOMA;

D O I：

10.3109/10428199209053611

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have suggested a growth stimulatory role of lymphoma cells in culture by interleukin 6. To test the hypothesis that IL-6 may have a role in vivo, the plasma of lymphoma patients was assayed for the presence of IL-6 bioactivity. A significantly greater proportion of lymphoma patients had elevated IL-6 levels (23 of 40) compared to controls (3 of 35). In follow-up, eight of 15 patients with previously elevated levels returned with decreased or undetectable levels of IL-6 post radio- or chemotherapy. This response was seen primarily in those with intermediate or high grade lymphomas. In contrast no change in IL-6 levels was seen in patients with low grade lymphoma despite measurable reductions in tumor size in both groups. © 1992 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：123 / 129

页数：7

共 37 条

[1]

Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas, Nature, 332, pp. 83-85, (1988)

[2]

Kishimoto T., Factors affecting B cell growth and differentiation, Annual Review of Immunology, 3, (1985)

[3]

Van Damme J., Opdenakker G., Simpson R.J., Rubira M.R., Caypas S., Vink A., Billiau A., Van Snick J., Identification of the human 26 kDa protein IFN-B2 as a B-cell hybridoma/plasmacytoma growth factor induced by IL-1 and TNF, Journal of Experimental Medicine, 165, (1987)

[4]

Klein B., Zhang X.G., Jordan M., Content J., Houssiau G., Aarden L., Piechaczyk M., Bataille R., Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6, Blood, 73, pp. 517-526, (1989)

[5]

Yee C., Biondi A., Wang H.-H., Iscove N.N., de Sousa J., Aarde L.A., Wong G.G., Clark S.D., Messner H.A., Minden M.D., A possible autocrine role for interleukin-6 in two lymphoma cell lines, Blood, 74, pp. 798-804, (1989)

[6]

Shimizu S., Hirano T., Yoshioka R., Sugai S., Matsuda T., Taga T., Kishimoto T., Konda S., Interleukin 6 (B-cell stimulatory factor 2) dependent growth of a Lennert's lymphoma derived T-cell line (KT-3), Blood, 72, pp. 1826-1828, (1988)

[7]

Zhang X.G., Klein B., Bataille R., Interleukin 6 is a potent myeloma growth factor in patients with aggressive multiple myeloma, Blood, 74, pp. 11-13, (1989)

[8]

Tweeddale M., Jamal N., Nguyen A., Wang X.-H., Minden M.D., Messner H.A., Production of growth factors by malignant lymphoma cell lines, Blood, 74, pp. 572-578, (1989)

[9]

Ikebuchi K., Wong G.G., Clark S.C., Ihle J.N., Hirai Y., Ogawa M., Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors, PNAS, 84, pp. 9035-9039, (1987)

[10]

Hoang T., Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblasts leukemia, Blood, 72, pp. 823-826, (1988)

← 1 2 3 4 →